---
source_image: "deposition-transcript+court-document+scanned-document+legal-filing__EFTA01389651_20260130_p001_i001.png"
source_pdf: "EFTA01389651.pdf"
method: pdf_text
words: 568
confidence: 1.00
extracted: 2026-02-13T16:26:30.447434
---

GLDUS132 EverWatch Financial 
Proprietary and Confidential 
ARTICLE 13 - AMENDMENTS, VOTING AND CONSENTS 
13.1 
AMENDMENTS. 
13.1.1 Consent of Partners. 
Except as otherwise provided in this Agreement, the terms and provisions of this Agreement may be 
waived on behalf of all Partners, modified, terminated or amended, during or after the term of the 
Partnership. with the prior written consent of the General Partner and a majority-in-interest of the Limited 
Partners: provided, however, that any provision of this Agreement requiring the written vote or consent of 
a greater percentage in interest of the Partners may be waived on behalf of all Partners, modified. 
terminated or amended only with the vote or written consent of the General Partner and such greater 
percentage in interest of the Partners as is required by such provision. Notwithstanding the other 
provisions of this Article 13, the General Partner, without the consent of any other Partner, may amend 
any provision of this Agreement (a) to the extent such amendment does not subject any Limited Partner to 
any material adverse economic consequences or diminish or waive in any material respect the duties and 
obligations of the General Partner to the Partnership or the Limited Partners, (b) to cure any ambiguity or 
correct or supplement any provision herein which may be inconsistent with any other provision herein or 
to correct any clerical errors or omissions in order that this Agreement shall accurately reflect the 
agreement among the Partners, (c) is necessary in order to comply with any fiscal, statutory or official 
requirement (whether or not having the force of law) and (d) to address changes in financial, regulatory or 
tax legislation, which amendment may include reorganizing or reconstituting the Partnership, but only to 
the extent such amendment does not materially adversely affect the economic returns of the Limited 
Partners. 
13.1.2 Amendments Affecting Partners' Economic Rights. 
No amendment shall increase the Subscription of any Limited Partner or dilute the interest of any Limited 
Partner relative to the interests of the other Limited Partners in the profits or capital of the Partnership or 
in allocations or distributions attributable to the ownership of such interest without the prior written 
consent of such Limited Partner, except such dilution as may result from additional Subscriptions from 
the Partners or the admission of Additional Limited Partners pursuant to this Agreement, and pursuant to 
an exercise of remedies by the Partnership under 3.3.3 and 6.3. 
13.1.3 Consent to Amend ERISA Provisions. 
Without the prior written consent of a majority-in-interest of all ERISA Partners, the text of 4.2, 1 1 .1.6(a) 
and this 13.1.3 shall not be amended. 
13.1.4 Notice of Amendments. 
The General Partner shall famish copies of any amendments to this Agreement to all Partners, other than 
changes in the List of Partners to reflect the admission, withdrawal or substitution of Partners, changes in 
the addresses of Partners or otherwise in accordance with 3.1, and changes in the Subscriptions of 
Partners (in each case occurring pursuant to this Agreement), which shall not require the consent of or 
notice to any Limited Partner. 
13.1.5 Negative Consent. 
Any consent or approval required pursuant to this Agreement or otherwise (including, without limitation, 
(i) any required consent to a transaction that would result in an "assignment" (within the meaning of the 
Otendov,er Accetec Secondary Opportunities IV (U.S.). L.P. 
36 
Amended and Ratided limited Partnership Agreanenl 
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) 
DB-SDNY-0094014 
CONFIDENTIAL 
SDNY_GM_00240198 
EFTA01389651
